Participates in the 3rd Japan Society of Aesthetic Medicine

IRVINE, Calif. -SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that CEO Yoshiyuki Aikawa, together with eight physicians from clinics managed by the Group, participated in the 3rd Japan Society of Aesthetic Medicine, held in Tokyo in October 2025, where they presented their research findings.

The Japan Society of Aesthetic Medicine brings together physicians with advanced expertise and extensive clinical experience in the field of aesthetic medicine. Dedicated to the pursuit of safe, evidence-based medical practices, the Society promotes ongoing academic exchange and professional development to contribute to the evolution and standardization of aesthetic medicine in Japan. The two-day event, held from October 25 (Sat) to October 26 (Sun), 2025, at TKP Garden City PREMIUM Kyobashi, featured a range of lectures, live demonstrations, and symposiums led by leading specialists. The conference provided a valuable platform for sharing clinical knowledge and research insights, fostering active discussions aimed at enhancing both the safety and quality of aesthetic medicine.

Serving as President of the Society, Dr. Aikawa was joined by Dr. Kazuhiro Ikawa, Dr. Hironobu Sakanishi, Dr. Ayaka Nishikawa, Dr. Go Kanazawa, Dr. Hiroaki Takizawa, Dr. Akinori Nakamizo, Dr. Atsushi Hayashi, and Dr. Yuna Yoshikawa-a total of nine presenters. Their selection reflected strong recognition of their prior academic contributions and clinical achievements. Through their presentations, SBC physicians highlighted the evolving role of aesthetic medicine beyond "visible change," reframing it as a discipline grounded in scientific evidence and reproducible outcomes. Case studies demonstrated practical approaches to improving safety and procedural consistency, earning wide engagement and praise from attendees.

In an era when aesthetic medicine has become an increasingly familiar choice for patients, SBC Medical Group continues to reaffirm its medical foundation-advancing scientific validation, technical standardization, and structured education programs. The Group remains committed to fostering academic exchange, promoting standardization, and enhancing the safety and reliability of aesthetic medical care, contributing to the establishment of trusted aesthetic medicine worldwide.

Overview of the 3rd Japan Society of Aesthetic Medicine

Venue: TKP Garden City PREMIUM Kyobashi Dates: October 25 (Sat) - October 26 (Sun), 2025 Official Website: https://nippon-biyou-ishikai-5umbpjz.gamma.site/

Presentation Topics

About SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/

Contacts
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: [email protected]
ICR LLC (In the US)
Bill Zima / Managing Partner Email: [email protected]